ArticleCancer immunology, immunotherapy : CII2022

Tafasitamab mediates killing of B-cell non-Hodgkin's lymphoma in combination with γδ T cell or allogeneic NK cell therapy.

Jung Hyun Her et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.